Pharmacopeia (PCOP) Tops Q3 View By 20c
More News related to PCOP
- Pharmacopeia (PCOP) Reduces Workforce by 28%
- Pharmacopeia (PCOP) Tops Q3 View By 20c
- Trading Radar for 11/06: Disney (DIS), Anheuser-Busch (BUD), NVIDIA (NVDA), Nasdaq (NDAQ), Toyota (TM), Priceline.com (PCLN) Reports; Initial Jobless Claims, Preliminary Productivity for Q3 Due
- Rodman & Renshaw Downgrades Pharmacopeia (PCOP) to Market Perform
- Unusual 11 Mid-Day Movers 9/25: TOPS, FRE, FNM, PCOP Higher; AMN, CRAI, PPC, MTN Lower
More News related to Earnings
- Compugen (CGEN) Announces Discovery of Biomarker CGEN-40001 for Type 2 Diabetes
- Northrop Grumman (NOC) To Sell TASC in $1.65B Cash Transaction
- Ball Corporation (BLL) Acquires Guangdong Jianlibao Group's 65% Interest in JV Metal Beverage Can Plant
- Enzon Pharmaceuticals (ENZN) to Sell Its Specialty Pharma Business to Sigma-Tau Group for Over $300 Million
- T. Rowe Price (TROW) Agrees to Acquire 26% Stake in UTI Asset Mgmt.
Pharmacopeia (Nasdaq: PCOP) reports Q3 loss of $0.25, 20 cents better than the analyst estimate of ($0.45). Revenue for the quarter was $5.9 million, versus the consensus of $6.15 million.
Related Categories
EarningsStocks Mentioned
+0.00Comments
WHATS GOING ON WITH THIS STOCK
DOES ANYBODY ELSE BESIDE ME OWN THIS STOCK AND WHATS HAPPENING WITH IT
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
pcop
pherm on Nov 26, 2008 07:07 PM????????????????